INIFY — INIFY Laboratories AB Income Statement
0.000.00%
Last trade - 00:00
- NOK375.47m
- NOK315.41m
- SEK1.19m
2022 December 31st | 2023 December 31st | |
---|---|---|
Period Length: | 14 M | 12 M |
Source: | ARS | ARS |
Standards: | SAS | SAS |
Status: | Final | Final |
Revenue | ||
Total Revenue | 0 | 1.19 |
Cost of Revenue | ||
Gross Profit | — | 0.852 |
Selling / General / Administrative Expenses | ||
Depreciation and Amortization | ||
Other Operating Expenses | ||
Total Operating Expenses | 44.6 | 57 |
Operating Profit | -44.6 | -55.8 |
Total Net Non Operating Interest Income / Expense | ||
Net Income Before Taxes | -44.2 | -53.3 |
Provision for Income Taxes | ||
Net Income After Taxes | -44.2 | -53.3 |
Net Income Before Extraordinary Items | ||
Net Income | -44.2 | -53.3 |
Income Available to Common Shareholders Excluding Extraordinary Items | ||
Income Available to Common Shareholders Including Extraordinary Items | ||
Diluted Net Income | -44.2 | -53.3 |
Diluted Weighted Average Shares | ||
Basic EPS Including Extraordinary Items | ||
Diluted EPS Including Extraordinary Items | ||
Diluted EPS Excluding Extraordinary Items | ||
Normalised Income Before Taxes | ||
Normalised Income After Taxes | ||
Normalised Income Available to Common Shareholders | ||
Diluted Normalised EPS | -1.28 | -1.18 |
Dividends per Share |